One Year Outcomes of 101 BeGraft Stent Grafts used as Bridging Stents in Fenestrated Endovascular Repairs

Spear, Rafaëlle; Sobocinski, Jonathan; Hertault, Adrien; Delloye, Matthieu; Azzauiu, Richard; Fabre, Dominique; Haulon, Stéphan

doi:10.1016/j.ejvs.2018.01.023

Cited by 43 publications

(39 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the clinical impact of this finding cannot be derived from the present study, it seems to correspond to the reported recently favorable early outcomes of the second-generation BeGs used as renal artery BSGs. 1 Moreover, the present study showed also a significant impact of the type of main device on the geometrical changes of the BSGs after fEVAR with larger L1/L2 ratios in the Zenith stent-graft vs the Anaconda. The most probable explanation is the greater stiffness of the Zenith owing to its Z-stent design compared to the ring stent and unsupported main body design of the Anaconda.…”

Section: Discussionsupporting

confidence: 60%

“…Today, there are 3 other balloon-expandable covered stents that have also been used as bridging stent-grafts (BSGs) in fEVAR procedures: the BeGraft (BeG; Bentley InnoMed, Hechingen, Germany), introduced in 2013, the LifeStream (BD/Bard, Tempe, AZ, USA), introduced in 2014, and the balloon-expandable Viabahn VBX (Gore Medical, Flagstaff, AZ, USA), introduced in 2018. Favorable outcomes with 99% TV patency after 1 year have been reported for the second-generation BeG stent-grafts in fEVAR, 1 and a recent in vitro study has confirmed their superior properties compared with the first-generation BeG. 2 Recently, the first positive results were also published about the Viabahn VBX used in fEVAR and branched EVAR (bEVAR).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Changes in Target Vessel Anatomy Following Fenestrated Endovascular Aneurysm Repair: Midterm Results

et al. 2020

View full text Add to dashboard Cite

Purpose: To analyze the changes in target vessel (TV) anatomy after fenestrated endovascular aneurysm repair (fEVAR) during midterm follow-up. Materials and Methods: A retrospective single-center study analyzed 56 patients (mean age 71±7 years; 49 men) who underwent fEVAR using custom-made stent-grafts (22 Zenith and 34 Anaconda) between June 2010 and July 2016. Advanta V12 (V12; 74, 53%) and BeGraft (BeG; 66, 47%) stent-grafts were used to bridge to the 140 TVs. Measurements of the TV deviation at the aortic origin, the vessel shift distal to the bridging stent-graft (BSG), and the outer and inner BSG curve lengths were performed after 3-dimensional reconstruction of the serial computed tomography angiography scans. The results of the measurements for the main devices, the TVs, and the bridging stent-grafts were compared using univariable and multivariable analysis. Results: Of the 140 BSGs examined (74 V12s and 66 BeGs), 393 measurements (38 celiac trunks, 102 superior mesenteric arteries, 121 left renal arteries, and 132 right renal arteries) were analyzed. The outer/inner BSG curve length ratio was larger after implantation of Zenith devices compared with Anaconda (p<0.001). The vessel shift distal to the BSG was significantly associated with the interaction of the TV and type of BSG only in the univariable analysis (p=0.001). There were no significant changes of the TV deviation at the aortic origin. Only the outer BSG curve length was significantly associated with TV complications (p=0.033). Median follow-up was 24 months (range 2–61). The BSG curve length ratio showed a significant increase over time (p<0.001) but did not differ between the BeG and V12 (p=0.381). Conclusion: No difference was found between the V12 and the BeG stent-grafts regarding anatomical TV changes during midterm follow-up after fEVAR. Both stent-grafts adapt to the TV anatomy over time, and moderate anatomical changes seem to be tolerated without increasing the risk for TV complications. The type of main device also influences the TV anatomy.

show abstract

Section: Discussionsupporting

confidence: 60%

Section: Introductionmentioning

confidence: 99%

Changes in Target Vessel Anatomy Following Fenestrated Endovascular Aneurysm Repair: Midterm Results

et al. 2020

View full text Add to dashboard Cite

show abstract

“…13,16,19,20) The single-centre prospective study series report 1-year outcomes of 101 BeGraft stent grafts used as bridging stents during FEVAR as a 98% patency rate. 21) Analysing the literature is difficult as a mix of complex abdominal AAA and thoraco-abdominal aneurysm are reported. 21)…”

Section: Discussionmentioning

confidence: 99%

“…21) Analysing the literature is difficult as a mix of complex abdominal AAA and thoraco-abdominal aneurysm are reported. 21)…”

Section: Discussionmentioning

confidence: 99%

Jotec E-Ventus BX Stent Graft Deployment in the FEVAR and Iliac Branch Device: Single Centre Experience

Sayed

Ahmed

Rodway

et al. 2019

Annals of Vascular Diseases

View full text Add to dashboard Cite

Objectives : To evaluate the outcomes of the E-ventus BX balloon-expandable stent graft system (Jotec, Hechingen, Germany) implanted as bridging stent grafts during fenestrated endovascular aortic repair (FEVAR) and the iliac branch device (IBD) of complex aneurysms. Methods : This was a single centre retrospective analysis prospective study including all consecutive patients treated by FEVAR and the IBD performed with E-ventus BX stent grafts as bridging stents. Demographics of patients, the diameter and length of the bridging stent grafts, technical success, reinterventions, occlusions, post-operative events, and imaging (computed tomography [CT] scan and ultrasound) were prospectively collected in an electronic database. Follow-ups were performed with clinical assessment and a CT angiogram scan at four weeks after discharge followed by a duplex ultrasound every six months for two years and then a yearly duplex scan afterwards. Results : Between June 2015 and October 2017, 40 consecutive patients (three females) were treated with custom made fenestrated endografts and the iliac branch device for complex aneurysms, using the E-Ventus BX stent graft. All 82 E-Ventus BX stent grafts were successfully delivered and deployed. There was no in-hospital mortality. The early bridging stents patency rate was 97.6% (80 out of 82). The two-target vessel post-operative occlusion was secondary to kink of the renal stents and failure for re-lining of the renal artery. Of the two patients, only one needed permanent dialysis. On the late follow-up (after 30 days), two other patients demonstrated a renal stent occlusion, with one treated successfully with re-lining of the stent and the other patient treated conservatively. Neither of them needed permanent dialysis. A follow-up was maintained for 36 patients until April 2018 with a median follow-up of 18 months. All bridging stents E-Ventus BX stent grafts remained patent (78 out of 82, 95.1%). Conclusion : E-Ventus BX stent grafts used as bridging stents during FEVAR and the IBD are associated with favourable outcomes at the mid-term follow-up. Long-term follow-up is required to confirm these promising results.

show abstract

“…Stephan Haulon's group reports early results using a new bridging stent to seal target side branch vessels during custom fenestrated stent repair. 1 The latest generation of the BeGraft stent has been modified by doubling the thickness of the expanded polytetrafluoroethylene covering used in the first generation device. It differs from other commonly used stents by being made of cobalt chromium rather than stainless steel and is available in a greater range of length and diameter combinations.…”

mentioning

confidence: 99%